Biofrontera Balance Sheet Health
Financial Health criteria checks 5/6
Biofrontera has a total shareholder equity of €17.3M and total debt of €461.0K, which brings its debt-to-equity ratio to 2.7%. Its total assets and total liabilities are €28.0M and €10.8M respectively. Biofrontera's EBIT is €4.0M making its interest coverage ratio -574.4. It has cash and short-term investments of €1.6M.
Key information
2.7%
Debt to equity ratio
€461.00k
Debt
| Interest coverage ratio | -574.4x |
| Cash | €1.64m |
| Equity | €17.26m |
| Total liabilities | €10.78m |
| Total assets | €28.04m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B8FK's short term assets (€16.4M) exceed its short term liabilities (€10.2M).
Long Term Liabilities: B8FK's short term assets (€16.4M) exceed its long term liabilities (€575.0K).
Debt to Equity History and Analysis
Debt Level: B8FK has more cash than its total debt.
Reducing Debt: B8FK's debt to equity ratio has reduced from 157% to 2.7% over the past 5 years.
Debt Coverage: B8FK's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: B8FK earns more interest than it pays, so coverage of interest payments is not a concern.